Uniform Small Graphene Oxide as an Efficient Cellular Nanocarrier for Immunostimulatory CpG Oligonucleotides
Source abstract
Abstract
Graphene oxide (GO) has attracted more and more attention as a promising nanomaterial in biomedical research and applications. In this study, we explore the ability of GO as nanocarrier for synthetic DNA strands. Immunostimulatory CpG oligodeoxynucleotides (ODNs) are attached to Poly-L-Lysine (PLL) functionalized, polydisperse GO, or uniform small GO (sGO) nanosheets. Both types of GO-CpG ODN nanoconjugates can be delivered into murine Raw264.7 macrophages and possess immunostimulatory activity, while sGO-CpG appears to be a more efficient stimulator. In addition, sGO-CpG nanosheets exhibit higher cellular uptake but better biocompatibility compared to the larger GO-CpG counterpart. Furthermore, PLL functionalized sGO-CpG has higher immunostimulatory activity than azide functionalized sGO-CpG. Together, our studies provide evidence that sGO can be utilized as an ideal intracellular nanocarrier for synthetic single-stranded DNA, and sGO-PLL-CpG conjugates may serve as a potential proinflammatory therapeutic tool.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Life Sciences, Nanjing Agriculture University, Nanjing 210095, China
Division of Physical Biology and Bioimaging Center, Shanghai Synchrotron Radiation Facility, CAS Key Laboratory of Interfacial Physics and Technology, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
Department of Neurology, Shanghai Tenth People’s Hospital, School of Medicine, Shanghai 200072, China
References (49)
Show source-provided references
1. Dorsett Y. · Nat. Rev. Drug Discovery · 2004 · 3 · 31810.1038/nrd1345 ↗
2. Agrawal S. · Curr. Opin. Chem. Biol. · 1998 · 2 · 51910.1016/S1367-5931(98)80129-4 ↗
3. Lebedeva I. · Annu. Rev. Pharmacol. Toxicol. · 2001 · 41 · 40310.1146/annurev.pharmtox.41.1.403 ↗
4. Seferos D. S. · Nano Lett. · 2009 · 9 · 30810.1021/nl802958f ↗
5. Gopalakrishnan B. · Methods Mol. Biol. · 2009 · 480 · 3110.1007/978-1-59745-429-2_3 ↗
6. Mintzer M. A. · Chem. Rev. · 2009 · 109 · 25910.1021/cr800409e ↗
7. Dhar S. · J. Am. Chem. Soc. · 2009 · 131 · 1465210.1021/ja9071282 ↗
8. Giljohann D. A. · J. Am. Chem. Soc. · 2009 · 131 · 207210.1021/ja808719p ↗
9. Viktoriya S. · Angew. Chem., Int. Ed. · 2008 · 47 · 138210.1002/anie.200703039 ↗
10. Lee J. H. · Adv. Drug Delivery Rev. · 2010 · 62 · 59210.1016/j.addr.2010.03.003 ↗
11. Li J. · Adv. Mater. · 2013 · 25 · 438610.1002/adma.201300875 ↗
12. Zhang X. · Carbon. · 2011 · 49 · 98610.1016/j.carbon.2010.11.005 ↗
13. Shen H. · Theranostics · 2012 · 2 · 28310.7150/thno.3642 ↗
14. Robinson J. T. · J. Am. Chem. Soc. · 2011 · 133 · 682510.1021/ja2010175 ↗
15. Tang J. · ACS Appl. Mater. Interfaces · 2013 · 5 · 386710.1021/am4005495 ↗
16. Peng C. · Small · 2010 · 6 · 168610.1002/smll.201000560 ↗
17. Sun X. M. · Nano Res. · 2008 · 1 · 20310.1007/s12274-008-8021-8 ↗
18. Li F. · Nanoscale · 2010 · 2 · 102110.1039/b9nr00401g ↗
19. Wen Y. · Chem. Commum. · 2011 · 47 · 627810.1039/c1cc11486g ↗
20. Liu Z. · J. Am. Chem. Soc. · 2008 · 130 · 1087610.1021/ja803688x ↗
21. Zhang L. M. · Small · 2010 · 6 · 53710.1002/smll.200901680 ↗
22. Tan X. · ACS Appl. Mater. Interfaces · 2013 · 5 · 137010.1021/am302706g ↗
23. Singh S. K. · ACS Nano · 2012 · 6 · 273110.1021/nn300172t ↗
24. Hummers W. S. · J. Am. Chem. Soc. · 1958 · 80 · 133910.1021/ja01539a017 ↗
25. Chung C. · Acc. Chem. Res. · 2013 · 46 · 221110.1021/ar300159f ↗
26. Sun X. M. · ACS Nano · 2010 · 4 · 338110.1021/nn1000386 ↗
27. Wang X. · J. Am. Chem. Soc. · 2011 · 133 · 633810.1021/ja200218y ↗
28. Zhang H. · ACS Appl. Mater. Interfaces · 2013 · 5 · 176110.1021/am303005j ↗
29. Krieg A. M. · Annu. Rev. Immunol. · 2002 · 20 · 70910.1146/annurev.immunol.20.100301.064842 ↗
30. Krieg A. M. · Nature · 1995 · 374 · 54610.1038/374546a0 ↗
31. Agrawal S. · Trends. Mol. Med. · 2002 · 8 · 11410.1016/S1471-4914(01)02264-X ↗
32. Hemmi H. · J. Immunol. · 2003 · 170 · 305910.4049/jimmunol.170.6.3059 ↗
33. Krieg A. M. · Nat. Rev. Drug Discovery · 2006 · 5 · 47110.1038/nrd2059 ↗
34. Wu F. · Vaccine · 2009 · 27 · 432010.1016/j.vaccine.2009.04.075 ↗
35. Kim H. A. · Cancer Lett. · 2009 · 274 · 16010.1016/j.canlet.2008.09.014 ↗
36. Klinman D. M. · Nat. Rev. Immunol. · 2004 · 4 · 24810.1038/nri1329 ↗
37. Olbert P. J. · Anticancer Res. · 2009 · 29 · 2067
38. Beaudette T. T. · Mol. Pharmaceutics · 2009 · 6 · 116010.1021/mp900038e ↗
39. Zwiorek K. · Pharm. Res. · 2008 · 25 · 55110.1007/s11095-007-9410-5 ↗
40. Wilson K. D. · Adv. Drug Delivery Rev. · 2009 · 61 · 23310.1016/j.addr.2008.12.014 ↗
41. Jain S. · Biomacromolecules · 2005 · 6 · 259010.1021/bm0503221 ↗
42. Fonseca D. E. · Adv. Drug Delivery Rev. · 2009 · 61 · 25610.1016/j.addr.2008.12.007 ↗
43. Rattanakiat S. · Biomaterials · 2009 · 30 · 570110.1016/j.biomaterials.2009.06.053 ↗
44. Bianco A. · J. Am. Chem. Soc. · 2005 · 127 · 5810.1021/ja044293y ↗
45. Wei M. · Angew. Chem., Int. Ed. Engl. · 2012 · 51 · 120210.1002/anie.201105187 ↗
46. Li J. · ACS Nano · 2011 · 5 · 878310.1021/nn202774x ↗
47. Chen N. · Small · 2013 · 10 · 36810.1002/smll.201300903 ↗
48. Wang Z. · Nanoscale · 2012 · 4 · 39410.1039/C1NR11174D ↗
49. Shan C. · Langmuir · 2009 · 25 · 1203010.1021/la903265p ↗